DNB Fund - Biotechnology Retail A (EUR)
WKN A40FC7 | ISIN LU2814038266 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU1540961759 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | -4,56 % | +19,05 % | -0,35 |
|
| 2 | LU1540962054 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | -5,05 % | +19,87 % | -0,36 |
|
| 3 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -6,31 % | +21,26 % | -0,40 |
|
| 4 | LU0942225912 | Candriam Equities L Biotechnology, R - Capitalisation | -6,53 % | +21,24 % | -0,41 |
|
| 5 | LU0317020203 | Candriam Equities L Biotechnology, V - Capitalisation | -6,86 % | +21,08 % | -0,43 |
|
| 79 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -35,43 % | +31,67 % | -1,19 |
|
| 80 | DE000A3DCA95 | BIT Biotech Opportunities S | -35,49 % | +31,65 % | -1,19 |
|
| 81 | LU0767968745 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | -12,84 % | +12,45 % | -1,20 |
|
| 82 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | -16,04 % | +14,16 % | -1,28 |
|
| 83 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -16,62 % | +14,16 % | -1,33 |
|